Drug Type Recombinant polypeptide |
Synonyms CNT-101, CNT101, CNT101A |
Target |
Mechanism TLR5 agonists(Toll like receptor 5 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Graft Versus Host Disease | Phase 1 | KR | - | |
Acute Radiation Syndrome | Phase 1 | KR | - | |
Stomatitis | Phase 1 | KR | - | |
Graft vs Host Disease | Preclinical | US | 23 Aug 2024 |